FindTrial
Sign In

The Correlation Between Genetic Polymorphism, Platelet Activity, Clopidogrel Responsiveness, and Serum Adipokine Concentration in Asian Acute Coronary Syndrome Patients

The Correlation Between Genetic Polymorphism, Platelet Activity, , Clopidogrel Responsiveness, and Serum Adipokine Concentration in Asian Acute Coronary Syndrome Patients

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01255267
Enrollment
Unknown
Registered
2010-12-07
Start date
Unknown
Completion date
Unknown
Last updated
2010-12-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Coronary Syndrome, Chronic Coronary Artery Disease

Keywords

Acute coronary syndrome and chronic coronary artery disease patients

Brief summary

In this study, we evaluate the acute coronary syndrome patients to see if there is correlation between platelet activity, genetic polymorphism (CYP2C19 and ABCB1), serum adipokines level, and Clopidogrel responsiveness.

Interventions

None listed

Sponsors

China Medical University Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1. Age \> 18 y/o 2. Acute coronary syndrome patients 3. Chronic coronary artery disease patients 4. Healthy volunteers

Exclusion criteria

1. Patient refusal 2. Allergy to Clopidogrel 3. Receive Gp IIb/IIIa inhibitor simultaneously 4. Cancer history 5. Severe renal and liver function impairment 6. Coagulopathy

Countries

Taiwan

Contacts

Primary ContactYu-Chen Wang, MD
richard9250@yahoo.com.tw886-4-22052121

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026